Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Reporting Calendar

Reporting date Details of report
31 October 2023 Quarterly Report
31 August 2023 Half-Yearly Report
31 July 2023 Quarterly Report
26 May 2023 FY22 AGM Chair & Managing Director Address
30 April 2023 Annual Report / Quarterly Report
28 February 2023 Preliminary Final Report
2 February 2023 General Meeting
30 January 2023 Quarterly Report

Investor contacts

Investor queries

Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474